Status:
UNKNOWN
Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICU
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Acute Respiratory Distress Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Renal damage in patients hospitalized for ARDS in the ICU can also be related to multiple causes including, but not limited to, the consequences of hemodynamic fluctuations in these patients or the us...
Eligibility Criteria
Inclusion
- Patients over 18 years of age
- Diagnosed Covid-19 by RT PCR
- Hospitalized in intensive care for management of complications related to Covid-19 from March 1, 2020 to April 20, 2020
- Patient not having expressed his or her opposition, after information, to the re-use of his or her data for the purposes of this research.
Exclusion
- \- Subject who expressed opposition to participating in the study
Key Trial Info
Start Date :
April 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2020
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT04385004
Start Date
April 27 2020
End Date
July 1 2020
Last Update
May 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service Reanimation Medicale
Strasbourg, France, 67091